<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8366">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05052333</url>
  </required_header>
  <id_info>
    <org_study_id>UOtago</org_study_id>
    <nct_id>NCT05052333</nct_id>
  </id_info>
  <brief_title>Examine the Psychosocial Impacts of Covid-19 Pandemic.</brief_title>
  <official_title>An International Study Examining the Psychosocial Impacts of Covid-19 Pandemic.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Otago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Quaid-e-Azam University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International Islamic University, Islamabad</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universitas Ahmad Dahlan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gadjah Mada University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ibn Sina University of Medical and Pharmaceutical Sciences, Iraq</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Al-Mustansiriyah University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hasan Kalyoncu University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>State University of New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Malaya</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Otago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an observational study examining the psychosocial impacts of the COVID-19 pandemic in&#xD;
      several low-resource countries (Pakistan, Bangladesh, Iraq, Somalia, Indonesia, Malaysia,&#xD;
      Turkey) and an English-speaking country (USA). The data will be obtained on the measures of&#xD;
      wellbeing (WHO Well-Being Index), psychological distress (Kessler 10), post-traumatic stress&#xD;
      (PTSD Checklist for DSM-5), post-traumatic growth (Posttraumatic Growth Inventory), and&#xD;
      pandemic-related stress (Covid Psychosocial Impacts Scale). Depending on the context, the&#xD;
      data will be collected employing either a unilingual (in native language) or bilingual online&#xD;
      survey (with English as a second language) from 500 participants (aged 18 and above) in each&#xD;
      of the eight locations using non-probability convenient sampling. Where applicable in some&#xD;
      countries (Malaysia, Turkey, and Somalia), a follow-up survey will be repeated in the same&#xD;
      cohort, which will provide a comparable data set longitudinally. The findings will enable us&#xD;
      to examine the psychosocial impacts of COVID-19; validate the translations of the CPIS and&#xD;
      standardized measures; and determine the trajectory of study variables with pandemic&#xD;
      exposure.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Examining the psychosocial impacts of the COVID-19 pandemic.</measure>
    <time_frame>The time it takes to perform the initial assessment varies, but it usually takes about 9 months. The follow-up longitudinal assessments (Turkey, Somalia) will take an average of two years to complete once the study is completed.</time_frame>
    <description>To explore the psychosocial impacts of the Covid-19 pandemic on self-report questionnaires of wellbeing (WHO-5), psychological distress (K10), post-traumatic stress (PCL-5), post-traumatic growth (PTGI), and pandemic-related stress (CPIS) in several low-resource countries and an English-speaking country. The data will be collected employing a unilingual (Indonesia, Bangladesh, Turkey, USA) or bilingual (Pakistan, Malaysia, Iraq, Somalia) survey. Where applicable, a follow-up survey will be repeated longitudinally (Malaysia, Turkey, and Somalia). With-in-subjects and between-subjects designs together with exploratory regression analyses will be employed to characterize this outcome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analyzing the reliability of CPIS in another English speaking country where there have been higher rates of COVID-19 infection.</measure>
    <time_frame>The study will take an average of 9 months to complete.</time_frame>
    <description>Although, the validation of the newly developed CPIS has already been examined in New Zealand. But, relatively speaking, New Zealand has fared well and it is desirable to validate the CPIS in a different English-speaking COVID-19 context, where there have been higher rates of COVID-19 infection. The data will be collected employing a one-off unilingual (English) survey in the USA. Several standardized questionnaires of wellbeing (WHO-5, PTGI) and distress (K10, PCL-5) will be employed together with the CPIS to examine validity. The metric used to characterize this outcome involves reliability (internal consistency, test-retest reliability) and validity (convergent, discriminant) analyses.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Analyzing the psychometric properties of the translations of the newly developed CPIS and other standardized measures.</measure>
    <time_frame>The time it takes to perform the initial assessment varies, but it usually takes about 9 months. The follow-up longitudinal assessments (Turkey, Somalia) will take an average of two years to complete.</time_frame>
    <description>The findings will give psychometric information on the translations and suitability of use of the newly developed CPIS and other standardized questionnaires (K10, WHO-5, PCL-5, PTGI) in several low-resource countries. The findings will help determine the quality of translations and their appropriateness for usage in the target population. The data will be collected employing a unilingual (Indonesia, Bangladesh, Turkey) or bilingual (Pakistan, Malaysia, Iraq, Somalia) survey. Where applicable, a follow-up survey will be repeated longitudinally (Malaysia, Turkey, and Somalia). The metric used to characterize this outcome involves reliability (internal consistency, test-retest reliability) and validity (convergent, discriminant) analyses.</description>
  </other_outcome>
  <other_outcome>
    <measure>Analyzing the longitudinal trajectory of the psychosocial impacts of the Covid-19 pandemic.</measure>
    <time_frame>The time to complete the study can vary but it will be completed in an average of 2 years.</time_frame>
    <description>The data will be obtained longitudinally in some countries to understand the trajectory of psychosocial impacts and to examine the degree of changes over time. The data will be collected employing a unilingual (Turkey) or bilingual (Somalia) survey and it will comprise of several self-report questionnaires of wellbeing (WHO-5), psychological distress (K10), post-traumatic stress (PCL-5), post-traumatic growth (PTGI), and newly developed measures of pandemic-related stress (CPIS). A follow-up survey will be repeated longitudinally in the same cohort. The metric used to characterize this outcome involves tabular and graphical measures and the use of linear mixed model analysis.</description>
  </other_outcome>
  <number_of_groups>8</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Psychosocial Stressor</condition>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Examining the psychosocial impacts of Covid-19 in Pakistan.</arm_group_label>
    <description>This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off bilingual (Urdu-English) survey. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Examining the psychosocial impacts of Covid-19 in Iraq.</arm_group_label>
    <description>This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off bilingual (Arabic-English) survey. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Examining the psychosocial impacts of Covid-19 in Turkey.</arm_group_label>
    <description>This is exploratory research and data will be obtained on a set of measures (N=500) using a unilingual (Turkish) survey with longitudinal assessment after 3 weeks of initial assessment. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Examining the psychosocial impacts of Covid-19 in USA.</arm_group_label>
    <description>This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off unilingual (English) survey. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Examining the psychosocial impacts of Covid-19 in Bangladesh.</arm_group_label>
    <description>This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off unilingual (Bangla) survey. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Examining the psychosocial impacts of Covid-19 in Malaysia.</arm_group_label>
    <description>This is exploratory research and data will be obtained on a set of measures (N=500) using a bilingual (Malay-English) survey. Data will be obtained longitudinally after 12 months of initial assessment. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Examining the psychosocial impacts of Covid-19 in Indonesia.</arm_group_label>
    <description>This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off unilingual (Indonesian) survey. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Examining the psychosocial impacts of Covid-19 in Somalia.</arm_group_label>
    <description>This is exploratory research and data will be obtained on a set of measures (N=500) using a one-off bilingual (Somalia-English) longitudinally. No predefined conditions apply to explain the nature of the study group other than inclusion and exclusion criteria.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The participants will be recruited from the general population using convenience sampling&#xD;
        in each of the eight locations (Pakistan, Bangladesh, Iraq, Somalia, Indonesia, Malaysia,&#xD;
        Turkey, and the USA). The specific details (e.g., residents of a certain town) may vary&#xD;
        from country to country and it will be outlined by the international collaborators in local&#xD;
        ethics applications. This information will be added to the trial registrations site once&#xD;
        obtained.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 18 and above&#xD;
&#xD;
          -  Currently residing in the country of interest.&#xD;
&#xD;
          -  Additional inclusion criterion applies to bilingual studies; which is having English&#xD;
             as a second language.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Aged below 18 years.&#xD;
&#xD;
          -  Not residing in the country of interest.&#xD;
&#xD;
          -  Additional exclusion criterion applies to bilingual studies; which is not having&#xD;
             English as a second language.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Caroline Bell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Otago Christchurch, New Zealand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sandila Tanveer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Otago Christchurch, New Zealand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ruqayya Sulaiman-Hill, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Otago Christchurch, New Zealand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Porter, MRCPsych</last_name>
    <role>Study Director</role>
    <affiliation>University of Otago Christchurch, New Zealand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joseph Boden, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Otago Christchurch, New Zealand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ben Beaglehole, FRANZCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Otago Christchurch, New Zealand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shaystah Dean, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Otago Wellington, New Zealand</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philip Schluter, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Canterbury, New Zealand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Assistant Research Fellow</last_name>
    <phone>0064226986365</phone>
    <email>sandila.tanveer@otago.ac.nz</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195-1525</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Lori A Zoellner, PhD</last_name>
      <email>zoellner@uw.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitas Ahmad Dahlan</name>
      <address>
        <city>Yogyakarta</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <contact>
      <last_name>Irfan Yunianto</last_name>
      <email>yunir562@student.otago.ac.nz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitas Gadjah Mada</name>
      <address>
        <city>Yogyakarta</city>
        <country>Indonesia</country>
      </address>
    </facility>
    <contact>
      <last_name>Anggi Rahajeng</last_name>
      <email>anggi.rahajeng@ugm.ac.id</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ibn Sina University of Medical and Pharmaceutical Sciences</name>
      <address>
        <city>Baghdad</city>
        <country>Iraq</country>
      </address>
    </facility>
    <contact>
      <last_name>Wafaa N Al-Hussainni, Dr</last_name>
      <email>wafaa.cphliraq@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mustansiriyah University</name>
      <address>
        <city>Baghdad</city>
        <country>Iraq</country>
      </address>
    </facility>
    <contact>
      <last_name>Muthana A Majid Al-Masoodi, Dr</last_name>
      <email>muthana.uomscr@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universiti Malaya</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Amer S Amer Nordin, Dr</last_name>
      <email>amersiddiq@um.edu.my</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>International Islamic University</name>
      <address>
        <city>Islamabad</city>
        <zip>44000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <contact>
      <last_name>Mussarat Jabeen, PhD</last_name>
      <email>mussarat.jabeen@iiu.edu.pk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Quaid-i-Azam University</name>
      <address>
        <city>Islamabad</city>
        <zip>44000</zip>
        <country>Pakistan</country>
      </address>
    </facility>
    <contact>
      <last_name>Nelofar Rauf, PhD</last_name>
      <email>kiran_rauf@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hasan Kalyoncu Üniversitesi</name>
      <address>
        <city>Gaziantep</city>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Öğr. Ü Saadet Yapan, PhD</last_name>
      <email>saadet.yapan@hku.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Indonesia</country>
    <country>Iraq</country>
    <country>Malaysia</country>
    <country>Pakistan</country>
    <country>Turkey</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://apps.who.int/iris/handle/10665/331490</url>
    <description>World Health Organization (2021). Mental Health and Psychosocial Considerations During the COVID-19 Outbreak.</description>
  </link>
  <link>
    <url>http://www.crisissurvey.org/</url>
    <description>The Coronavirus Health Impact Survey (2019)</description>
  </link>
  <link>
    <url>https://www.COVIDminds.org/post/february-update-the-psychological-impact-of-COVID-19</url>
    <description>COVID-Minds (2020). The Psychological Impact of COVID-19.</description>
  </link>
  <link>
    <url>https://www.COVIDminds.org/mental-health-measures</url>
    <description>COVID-Minds (2020). Recommended Scales</description>
  </link>
  <reference>
    <citation>Bell C, Beaglehole B, Bell R, Tanveer S, Sulaiman-Hill R, Boden J, Porter R. Learning from previous disasters: Potential pitfalls of epidemiological psychosocial research in the COVID-19 environment. Aust N Z J Psychiatry. 2021 Jul;55(7):646-649. doi: 10.1177/0004867421998783. Epub 2021 Mar 1.</citation>
    <PMID>33645256</PMID>
  </reference>
  <reference>
    <citation>Bell C, Williman J, Beaglehole B, Stanley J, Jenkins M, Gendall P, Rapsey C, Every-Palmer S. Challenges facing essential workers: a cross-sectional survey of the subjective mental health and well-being of New Zealand healthcare and 'other' essential workers during the COVID-19 lockdown. BMJ Open. 2021 Jul 19;11(7):e048107. doi: 10.1136/bmjopen-2020-048107.</citation>
    <PMID>34281926</PMID>
  </reference>
  <reference>
    <citation>Dong F, Liu HL, Yang M, Lu CL, Dai N, Zhang Y, Robinson N, Liu JP. Immediate Psychosocial Impact on Healthcare Workers During COVID-19 Pandemic in China: A Systematic Review and Meta-Analysis. Front Psychol. 2021 May 28;12:645460. doi: 10.3389/fpsyg.2021.645460. eCollection 2021.</citation>
    <PMID>34122233</PMID>
  </reference>
  <reference>
    <citation>Fergusson DM, Boden JM, Horwood LJ, Mulder RT. Perceptions of distress and positive consequences following exposure to a major disaster amongst a well-studied cohort. Aust N Z J Psychiatry. 2015 Apr;49(4):351-9. doi: 10.1177/0004867414560652. Epub 2014 Nov 27.</citation>
    <PMID>25430912</PMID>
  </reference>
  <reference>
    <citation>Jenkins M, Hoek J, Jenkin G, Gendall P, Stanley J, Beaglehole B, Bell C, Rapsey C, Every-Palmer S. Silver linings of the COVID-19 lockdown in New Zealand. PLoS One. 2021 Apr 1;16(4):e0249678. doi: 10.1371/journal.pone.0249678. eCollection 2021.</citation>
    <PMID>33793672</PMID>
  </reference>
  <reference>
    <citation>Kessler RC, Barker PR, Colpe LJ, Epstein JF, Gfroerer JC, Hiripi E, Howes MJ, Normand SL, Manderscheid RW, Walters EE, Zaslavsky AM. Screening for serious mental illness in the general population. Arch Gen Psychiatry. 2003 Feb;60(2):184-9.</citation>
    <PMID>12578436</PMID>
  </reference>
  <reference>
    <citation>Tedeschi RG, Cann A, Taku K, Senol-Durak E, Calhoun LG. The Posttraumatic Growth Inventory: A Revision Integrating Existential and Spiritual Change. J Trauma Stress. 2017 Feb;30(1):11-18. doi: 10.1002/jts.22155. Epub 2017 Jan 18.</citation>
    <PMID>28099764</PMID>
  </reference>
  <reference>
    <citation>Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84(3):167-76. doi: 10.1159/000376585. Epub 2015 Mar 28. Review.</citation>
    <PMID>25831962</PMID>
  </reference>
  <reference>
    <citation>Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015 Dec;28(6):489-98. doi: 10.1002/jts.22059. Epub 2015 Nov 25.</citation>
    <PMID>26606250</PMID>
  </reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>September 19, 2021</study_first_submitted>
  <study_first_submitted_qc>September 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2021</study_first_posted>
  <last_update_submitted>December 14, 2021</last_update_submitted>
  <last_update_submitted_qc>December 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Otago</investigator_affiliation>
    <investigator_full_name>Sandila Tanveer</investigator_full_name>
    <investigator_title>Assistant Research Fellow</investigator_title>
  </responsible_party>
  <keyword>Psychosocial impacts</keyword>
  <keyword>Cross-cultural comparisons</keyword>
  <keyword>Reliability and validity</keyword>
  <keyword>Mental health</keyword>
  <keyword>Wellbeing</keyword>
  <keyword>Epidemiology</keyword>
  <keyword>Low resource countries</keyword>
  <keyword>Psychometric translations</keyword>
  <keyword>Observational study</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

